Cargando…

Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand Binding

Peroxisome proliferator-activated receptors (PPARs) have been intensively studied as drug targets to treat type 2 diabetes, lipid disorders, and metabolic syndrome. This study is part of our ongoing efforts to map conformational changes in PPARs in solution by a combination of chemical cross-linking...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarz, Rico, Tänzler, Dirk, Ihling, Christian H., Sinz, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4798536/ https://www.ncbi.nlm.nih.gov/pubmed/26992147 http://dx.doi.org/10.1371/journal.pone.0151412

Ejemplares similares

Molecular Details of Retinal Guanylyl Cyclase 1/GCAP-2 Interaction
por: Rehkamp, Anne, et al.
Publicado: (2018)

Native mass spectrometry identifies the HybG chaperone as carrier of the Fe(CN)(2)CO group during maturation of E. coli [NiFe]-hydrogenase 2
por: Arlt, Christian, et al.
Publicado: (2021)

Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes
por: Zhang, Chen, et al.
Publicado: (2020)

A rapid and reliable liquid chromatography/mass spectrometry method for SARS-CoV-2 analysis from gargle solutions and saliva
por: Kipping, Marc, et al.
Publicado: (2021)

Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention
por: Peters, Jeffrey M., et al.
Publicado: (2015)

Analysis of Nidogen-1/Laminin γ1 Interaction by Cross-Linking, Mass Spectrometry, and Computational Modeling Reveals Multiple Binding Modes
por: Lössl, Philip, et al.
Publicado: (2014)

Peroxisome Proliferator-Activated Receptor β/δ in the Brain: Facts and Hypothesis
por: Hall, M. G., et al.
Publicado: (2008)

The Potential Applications of Peroxisome Proliferator-Activated Receptor δ Ligands in Assisted Reproductive Technology
por: Huang, Jaou-Chen
Publicado: (2008)

Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis
por: Peters, Jeffrey M., et al.
Publicado: (2019)

Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma
por: Leone, Patrizia, et al.
Publicado: (2023)

Metabolic Functions of Peroxisome Proliferator-Activated Receptor β/δ in Skeletal Muscle
por: Gaudel, Céline, et al.
Publicado: (2007)

Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2022)

Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ)
por: Adhikary, Till, et al.
Publicado: (2011)

The Role of Peroxisome Proliferator-Activated Receptor β/δ on the Inflammatory Basis of Metabolic Disease
por: Coll, Teresa, et al.
Publicado: (2010)

Different Oligomeric States of the Tumor Suppressor p53 Show Identical Binding Behavior towards the S100β Homodimer
por: Wei, Alan An Jung, et al.
Publicado: (2022)

Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4
por: Khozoie, Combiz, et al.
Publicado: (2012)

Crystal structures of the ligand-binding domain of human peroxisome proliferator-activated receptor δ in complexes with phenylpropanoic acid derivatives and a pyridine carboxylic acid derivative
por: Oyama, Takuji, et al.
Publicado: (2022)

Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha)
por: Gordon, Darren M., et al.
Publicado: (2021)

Direct Observation of “Elongated” Conformational States in α‐Synuclein upon Liquid‐Liquid Phase Separation
por: Ubbiali, Daniele, et al.
Publicado: (2022)

Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
por: Pollock, Claire B., et al.
Publicado: (2010)

Activation of β-Adrenoceptors by Dobutamine May Induce a Higher Expression of Peroxisome Proliferator-Activated Receptors δ (PPARδ) in Neonatal Rat Cardiomyocytes
por: Chou, Ming-Ting, et al.
Publicado: (2012)

Conformational Changes in DNA upon Ligand Binding Monitored by Circular Dichroism
por: Chang, Yu-Ming, et al.
Publicado: (2012)

Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer
por: Montagner, Alexandra, et al.
Publicado: (2014)

Structural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand Binding
por: Batista, Fernanda A. H., et al.
Publicado: (2012)

Perfluoroalkyl Acid Binding with Peroxisome Proliferator-Activated Receptors α, γ, and δ, and Fatty Acid Binding Proteins by Equilibrium Dialysis with a Comparison of Methods
por: Khazaee, Manoochehr, et al.
Publicado: (2021)

Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor β/δ
por: Zhou, Xiaodan, et al.
Publicado: (2014)

Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor δ from Peroxisome proliferator-activated receptor γ in the ob/ob mouse
por: Roberts, Lee D, et al.
Publicado: (2009)

Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases
por: Kim, In Soo, et al.
Publicado: (2023)

Munc13-Like skMLCK Variants Cannot Mimic the Unique Calmodulin Binding Mode of Munc13 as Evidenced by Chemical Cross-Linking and Mass Spectrometry
por: Herbst, Sabine, et al.
Publicado: (2013)

Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench
por: Chang, Wei-Ting, et al.
Publicado: (2016)

Activation of Peroxisome Proliferator–Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleukin-6–Stimulated Adipocytes
por: Serrano-Marco, Lucía, et al.
Publicado: (2011)

Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism
por: Lee, Mi Young, et al.
Publicado: (2012)

Effects of Peroxisome Proliferator-Activated Receptor-δ Agonist on Cardiac Healing after Myocardial Infarction
por: Park, Jeong Rang, et al.
Publicado: (2016)

Cadmium Toxicity Is Regulated by Peroxisome Proliferator-Activated Receptor δ in Human Proximal Tubular Cells
por: Mori, Chikage, et al.
Publicado: (2022)

Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum
por: Edwards, Lariah, et al.
Publicado: (2019)

Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms
por: Yao, Pei-Li, et al.
Publicado: (2015)

Intracellular free fatty acid upholds β-cell glucose competence: The role of peroxisome proliferator-activated receptor δ and mitochondrial metabolism
por: Takei, Masahiro, et al.
Publicado: (2015)

Cardiac Peroxisome Proliferator-Activated Receptor δ (PPARδ) as a New Target for Increased Contractility without Altering Heart Rate
por: Chen, Zhih-Cherng, et al.
Publicado: (2013)

Ligands of the peroxisome proliferator-activated receptor γ inhibit hepatoce llular carcinoma cell proliferation
por: Jin, Zhe, et al.
Publicado: (2017)

Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review
por: Grygiel-Górniak, Bogna
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oos0imt9guf1i3dujjh25evc74